Handbook on Ovarian Cancer: Risk Factors, Therapies & Prognosis (Obstetrics Gynecology Advances)
Language: English
Published by Nova Science Pub Inc, 2015
- Hardcover
- New
Seller: Biblios, frankfurt am main, hessen, GermanyBiblios
4-star seller
AbeBooks seller since September 10, 2024
Hardcover
Condition: New
US$ 205.90
US$ 11.20 shipping
Ships from Germany to U.S.A.
Quantity: 4 available
Add to basketFree 30-day returns
Item description from seller
pp. 307.
Seller Inventory # 18375176449
- Title
- Handbook on Ovarian Cancer: Risk Factors, Therapies & Prognosis (Obstetrics Gynecology Advances)
- Publisher
- Nova Science Pub Inc
- Publication year
- 2015
- Condition
- New
- Binding
- Hardcover
- Language
- English
- ISBN 10
- 1634838742
- ISBN 13
- 9781634838740
Ovarian cancer is the third most diagnosed gynecologic cancer and the first leading cause of death from all of gynecological malignancies. High mortality of the patients is usually associated with the progression of the disease. Most patients are diagnosed within the advanced stages due to lacking relevant diagnostic and screening markers. This handbook discusses several risk factors of ovarian cancer. It also examines the different therapies provided to ovarian cancer patients, and the prognosis of the cancer.
"Synopsis" may belong to another edition of this title.
Biblios
frankfurt am main, hessen, Germany
4-star seller
AbeBooks seller since September 10, 2024
Shipping rates from Germany to U.S.A.
| Item | 25 to 45 business days | 8 to 14 business days |
|---|---|---|
| First item | US$ 11.20 | US$ 21.04 |
Payment methods
Store description
We carry a wide selection of books from South Asia, United States, UK.
Specialty
new books imported from india, uk, usaSeller's business information
Readingos GmbH
Kaiserstraße 47
Frankfurt am Main, Germany 60329
Shipping terms
To ensure faster delivery, books may be shipped from any of the following locations Germany, the United Kingdom (UK), the United States (US), based on the buyer's address and product availability.